These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 6337604
1. Beneficial effects of UK 37248, a thromboxane synthetase inhibitor, in experimental endotoxic shock in the rat. Halushka PV, Cook JA, Wise WC. Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):133S-139S. PubMed ID: 6337604 [Abstract] [Full Text] [Related]
2. Effects of a pyridine derivative thromboxane synthetase inhibitor and its inactive isomer in endotoxic shock in the rat. Anderegg K, Anzeveno P, Cook JA, Halushka PV, McCarthy J, Wagner E, Wise WC. Br J Pharmacol; 1983 Apr; 78(4):725-32. PubMed ID: 6687819 [Abstract] [Full Text] [Related]
3. Implications for thromboxane A2 in the pathogenesis of endotoxic shock. Wise WC, Cook JA, Halushka PV. Adv Shock Res; 1981 Apr; 6():83-91. PubMed ID: 6961767 [Abstract] [Full Text] [Related]
4. Protective effects of trans-13-APT, a thromboxane receptor antagonist, in endotoxemia. Olanoff LS, Cook JA, Eller T, Knapp DR, Halushka PV. J Cardiovasc Pharmacol; 1985 Apr; 7(1):114-20. PubMed ID: 2580129 [Abstract] [Full Text] [Related]
6. [Experimental study on the pathophysiology of endotoxin shock as analysed by alterations in thromboxane B2 and 6-keto-PGF1 alpha levels]. Baba H. Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):6-20. PubMed ID: 3283521 [Abstract] [Full Text] [Related]
7. Gentamicin and indomethacin in the treatment of septic shock: effects on prostacyclin and thromboxane A2 production. Butler RR, Wise WC, Halushka PV, Cook JA. J Pharmacol Exp Ther; 1983 Apr; 225(1):94-101. PubMed ID: 6339712 [Abstract] [Full Text] [Related]
8. Studies on the beneficial effects of aspirin in endotoxic shock. Relationship to inhibition of arachidonic acid metabolism. Halushka PV, Wise WC, Cook JA. Am J Med; 1983 Jun 14; 74(6A):91-6. PubMed ID: 6687979 [Abstract] [Full Text] [Related]
9. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581. Casey LC, Fletcher JR, Zmudka MI, Ramwell PW. J Pharmacol Exp Ther; 1982 Aug 14; 222(2):441-6. PubMed ID: 6896528 [Abstract] [Full Text] [Related]
10. Thromboxane and prostacyclin production during septic shock. Butler RR, Wise WC, Halushka PV, Cook JA. Adv Shock Res; 1982 Aug 14; 7():133-45. PubMed ID: 6753528 [Abstract] [Full Text] [Related]
11. In vivo redirection of prostaglandin endoperoxides into 6-keto PGF1 alpha formation by thromboxane synthetase inhibitors in the rat. Maguire ED, Wallis RB. Thromb Res; 1983 Oct 01; 32(1):15-27. PubMed ID: 6689221 [Abstract] [Full Text] [Related]
12. Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency. Cook JA, Wise WC, Halushka PV. J Clin Invest; 1980 Jan 01; 65(1):227-30. PubMed ID: 7350199 [Abstract] [Full Text] [Related]
18. Endotoxin-induced procoagulant activity, eicosanoid synthesis, and tumor necrosis factor production by rat peritoneal macrophages: effect of endotoxin tolerance and glucan. Moore JN, Cook JA, Morris DD, Halushka PV, Wise WC. Circ Shock; 1990 Jul 15; 31(3):281-95. PubMed ID: 2113440 [Abstract] [Full Text] [Related]
19. Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shock. Ball HA, Cook JA, Wise WC, Halushka PV. Intensive Care Med; 1986 Jul 15; 12(3):116-26. PubMed ID: 3016060 [Abstract] [Full Text] [Related]